Protective effect of octreotide and infliximab in an experimental model of indomethacin-induced inflammatory bowel disease

Digestive Diseases and Sciences

Volumn 53, Issue 9, 2008, Pages 2516-2520

  Cury, Dídia H Bismara ^a   Costa, José Edson ^b   Irika, Kioshi ^b   Mijji, Luciana ^b   Garcez, Alessandre ^b   Buchiguel, Carlos ^b   Silva, Ivani ^b   Sipahi, Aytan ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Antibodies; Enterocolitis; Inflammatory bowel diseases; Monoclonal infliximab; Octreotide

Indexed keywords

CHROMIUM 51; EDETIC ACID; INDOMETACIN; INFLIXIMAB; OCTREOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENTERITIS; INTESTINE EPITHELIUM; INTESTINE MUCOSA PERMEABILITY; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL MEMBRANE PERMEABILITY; CROHN DISEASE; DISEASE MODELS, ANIMAL; GASTROINTESTINAL AGENTS; INDOMETHACIN; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; OCTREOTIDE; RATS; RATS, WISTAR;

EID: 50249137214     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-0172-z     Document Type: Article

References (21)

1. CO Elson RB Sartor GS Tennyson RH Riddell 1995 Experimental models of inflammatory bowel disease Gastroenterology 109 4 1344 1367
2. W Strober 1985 Animal models of inflammatory bowel disease-an overview Dig Dis Sci 30 12 Suppl 3S 10S
3. TH Kent RM Cardelli FW Stamler 1969 Small intestinal ulcers and intestinal flora in rats given indomethacin Am J Pathol 54 2 237 249
4. M Peeters B Geypens D Claus H Nevens Y Ghoos G Verbeke 1997 Clustering of increased small intestinal permeability in families with Crohn's disease Gastroenterology 113 3 802 807
5. J Ford SW Martin JB Houston 1995 Assessment of intestinal permeability changes induced by nonsteroidal anti-inflammatory drugs in the rat J Pharmacol Toxicol Methods 34 1 9 16
6. T Mahmud S Somasundaram G Sigthorsson RJ Simpson S Rafi R Foster 1998 Enantiomers of flurbiprofen can distinguish key pathophysiological steps of NSAID enteropathy in the rat Gut 43 6 775 782
7. I Bjarnason G Zanelli P Prouse P Smethurst T Smith S Levi 1987 Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs Lancet 2 8561 711 714
8. RB Sartor 1994 Cytokines in intestinal inflammation: pathophysiological and clinical considerations Gastroenterology 106 2 533 539
9. V Bertrand R Guimbaud M Tulliez C Mauprivez P Sogni D Couturier 1998 Increase in tumor necrosis factor-alpha production linked to the toxicity of indomethacin for the rat small intestine Br J Pharmacol 124 7 1385 1394
10. P Suenaert V Bulteel L Lemmens M Noman B Geypens G Van Assche 2002 Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease Am J Gastroenterol 97 8 2000 2004
11. JD van Bergeijk JH Wilson OH Nielsen C von Tirpitz AL Karvonen I Lygren 2002 Octreotide in patients with active ulcerative colitis treated with high dose corticosteroids (OPUS 1) Eur J Gastroenterol Hepatol 14 3 243 248
12. R Eliakim F Karmeli E Okon D Rachmilewitz 1993 Octreotide effectively decreases mucosal damage in experimental colitis Gut 34 2 264 269
13. T Kucharzik A Lugering N Lugering K Rautenberg M Linnepe C Cichon 2000 Characterization of M cell development during indomethacin-induced ileitis in rats Aliment Pharmacol Ther 14 2 247 256
14. CF Bernardes-Silva AO Damiao AM Sipahi FR Laurindo K Iriya FP Lopasso 2004 Ursodeoxycholic acid ameliorates experimental ileitis counteracting intestinal barrier dysfunction and oxidative stress Dig Dis Sci 49 10 1569 1574
15. J Goncalves G Queiroz 1996 Purinoceptor modulation of noradrenaline release in rat tail artery: tonic modulation mediated by inhibitory P2Y- and facilitatory A2A-purinoceptors Br J Pharmacol 117 1 156 160
16. J Wyatt H Vogelsang W Hubl T Waldhoer H Lochs 1993 Intestinal permeability and the prediction of relapse in Crohn's disease Lancet 341 8858 1437 1439
17. A Garcia-Lafuente M Antolin F Guarner E Crespo JR Malagelada 2001 Modulation of colonic barrier function by the composition of the commensal flora in the rat Gut 48 4 503 507
18. C Hogenauer B Aichbichler C Santa Ana J Porter J Fordtran 2002 Effect of octreotide on fluid absorption and secretion by the normal human jejunum and ileum in vivo Aliment Pharmacol Ther 16 4 769 777
19. A Lamrani M Tulliez L Chauvelot-Moachon S Chaussade C Mauprivez AM Hagnere 1999 Effects of octreotide treatment on early TNF-alpha production and localization in experimental chronic colitis Aliment Pharmacol Ther 13 5 583 594
20. P Suenaert V Bulteel S Vermeire M Noman G Van Assche P Rutgeerts 2005 Hyperresponsiveness of the mucosal barrier in Crohn's disease is not tumor necrosis factor-dependent Inflamm Bowel Dis 11 7 667 673
21. S Colpaert Z Liu B De Greef P Rutgeerts JL Ceuppens K Geboes 2001 Effects of anti-tumour necrosis factor, interleukin-10 and antibiotic therapy in the indometacin-induced bowel inflammation rat model Aliment Pharmacol Ther 15 11 1827 1836